Riskpilot← Back to searchSign inGet full accessKurm Pharma ApS
APSActiveCVR 39181274Ferrarivej 12Manufacture of perfumes and toilet preparations · NACE 2042Est. 2017— employees
Revenue 2024
DKK 331K
+264% vs 2023
EBITDA margin
100.0%
+264% vs 2023
Equity ratio
59.6%
Financial strength
Net profit 2024
DKK 602K
+149% vs 2023
| Revenue | DKK 331K | +264% |
| EBITDA | DKK 331K | +264% |
| Net profit | DKK 602K | +149% |
| Total assets | DKK 6,9M | +42% |
| Equity | DKK 4,1M | +17% |
| Employees | — | — |
Legal name
Kurm Pharma ApS
CVR number
39181274
Legal form
Anpartsselskab
NACE code
2042 · Manufacture of perfumes and toilet preparations
Founded
18. december 2017
Share capital
DKK 50.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med salg af kosttilskud og kosmetiske produkter på det internationale marked.
Address
Ferrarivej 12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 494 | 667 | 947 | 2.610 | 459 | 91 | 331 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 494 | 667 | 947 | 2.610 | 459 | 91 | 331 |
| Depreciation & amort. | -48 | -48 | -48 | -48 | -48 | -48 | -52 |
| EBIT | 446 | 619 | 899 | 2.562 | 411 | 43 | 279 |
| Net financials | -1 | 31 | 7 | -1 | 21 | 267 | 494 |
| Profit before tax | 446 | 650 | 906 | 2.561 | 432 | 310 | 773 |
| Tax | 98 | 143 | 201 | 565 | 100 | 68 | 171 |
| Net profit | 348 | 506 | 705 | 1.996 | 333 | 242 | 602 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 3.127 | 3.869 | 4.286 | 4.850 | 3.697 | 4.841 | 6.870 |
| Equity | 398 | 904 | 969 | 3.105 | 3.248 | 3.489 | 4.092 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.729 | 2.964 | 3.317 | 1.745 | 449 | 1.351 | 2.779 |
| Total debt | 2.729 | 2.964 | 3.317 | 1.745 | 449 | 1.351 | 2.779 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20182024
Equity ratio
59.6%
This company
38.2%
Market median
+56% vs market
20182024
Return on equity
14.7%
This company
18.4%
Market median
+20% vs market
20182024
Net profit margin
181.9%
This company
8.1%
Market median
+2146% vs market
20182024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20182024
Debt / equity
0.68×
This company
0.62×
Market median
+10% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2017-12-18 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JG Management | Management | 2017 | — | — |
JG Management | Management | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2018 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Fitzrovia ApS | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PIMLICO ApS
Kurm Pharma ApS Board members of Kurm Pharma ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jacob Gjelstrup | Management | 0 companies |
| Jesper Gjelstrup | Management | 0 companies |
| Peter Vammen | Chairman | 0 companies |
| Steen Nordstrøm | Chairman | 0 companies |
| Johannes Gjelstrup | Board of Directors | 0 companies |
| Allan Christensen | Board of Directors | 0 companies |